Pear Therapeutics, Inc. (PEAR) financial statements (2022 and earlier)

Company profile

Business Address 200 STATE STREET
BOSTON, MA 02109
State of Incorp. DE
Fiscal Year End December 31
SIC 80 - Health Services (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments174,571
Cash and cash equivalents169,567
Short-term investments5,004
Receivables1,794
Other undisclosed current assets8,876
Total current assets:185,241
Noncurrent Assets
Property, plant and equipment6,255
Restricted cash and investments411
Other noncurrent assets5,253
Total noncurrent assets:11,919
TOTAL ASSETS:197,160
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities17,192
Accounts payable1,806
Accrued liabilities3,531
Employee-related liabilities11,855
Deferred revenue421
Debt26,993
Other undisclosed current liabilities2,560
Total current liabilities:47,166
Noncurrent Liabilities
Liabilities, other than long-term debt50,357
Other liabilities1,994
Business combination, contingent consideration, liability48,363
Other undisclosed noncurrent liabilities9,203
Total noncurrent liabilities:59,560
Total liabilities:106,726
Stockholders' equity
Stockholders' equity attributable to parent90,434
Common stock14
Additional paid in capital338,404
Accumulated other comprehensive loss(1)
Accumulated deficit(247,983)
Total stockholders' equity:90,434
TOTAL LIABILITIES AND EQUITY:197,160

Income statement (P&L) ($ in thousands)

12/31/2021
Revenues4,208
Cost of revenue(5,233)
Gross profit:(1,025)
Operating expenses(104,660)
Operating loss:(105,685)
Nonoperating income
(Other Nonoperating income)
40,543
Net loss available to common stockholders, diluted:(65,142)

Comprehensive Income ($ in thousands)

12/31/2021
Net loss:(65,142)
Comprehensive loss:(65,142)
Other undisclosed comprehensive loss, net of tax, attributable to parent(1)
Comprehensive loss, net of tax, attributable to parent:(65,143)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: